Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 186

The DOI matches its Crossref record.

Treatment with Piperacillin‐Tazobactam and False‐Positive Aspergillus Galactomannan Antigen Test Results for Patients with Hematological Malignancies

Adam, Olivier, Auperin, Anne, Wilquin, Fanny, Bourhis, Jean‐Henri, Gachot, Bertrand, Chachaty, Elisabeth · 2004 · Clinical Infectious Diseases

Abstract

We report the occurrence of a high rate of false-positive test results during the surveillance of hematology patients for galactomannan (GM) antigenemia. Among 218 patients surveyed from June 2002 through June 2003, 42 (19.3%) had > or =1 serum sample positive for GM (optical density index, >1.5). Of these patients, 38 had no additional evidence of invasive aspergillosis, and, therefore, their test results were considered to be false-positives. Case-control analysis showed that treatment with piperacillin-tazobactam was the only risk factor significantly associated with receiving false-positive test results. When tested for GM antigen, 3 of 4 piperacillin-tazobactam batches had positive results. Physicians should be aware of the possible interference of treatment with piperacillin-tazobactam when interpreting the results of the GM assay.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/383148

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 186

Metadata

Authors
Adam, O., Auperin, A., Wilquin, F., Bourhis, J., Gachot, B., & Chachaty, E.
Venue
Clinical Infectious Diseases
Published
2004-03-15
Volume
38
Issue
6
Pages
917-920
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W1997330385
Cited by
186
References
0
FWCI
14.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment with Piperacillin‐Tazobactam and False‐Positive Aspergillus Galactomannan Antigen Test Results for Patients with Hematological Malignancies. https://app.cochat.ai/papers/10.1086/383148
The paper
Adam, O., Auperin, A., Wilquin, F., Bourhis, J., Gachot, B., & Chachaty, E. (2004). Treatment with Piperacillin‐Tazobactam and False‐Positive Aspergillus Galactomannan Antigen Test Results for Patients with Hematological Malignancies. Clinical Infectious Diseases. https://doi.org/10.1086/383148

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.